Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma
Naotake Funamizu(Ehime University), S. Perwez Hussain(National Institutes of Health), Timothy Back(Science Applications International Corporation (United States)), Nader Hanna(University of Maryland, Baltimore), Jochen Gaedcke(Universitätsmedizin Göttingen), Thomas Ried(National Institutes of Health), Jeffrey Subleski(National Cancer Institute), Chaoxin Hu(Johns Hopkins University), Anirban Maitra(NYU Langone Health), Katsuhiko Yanaga(Sanno Medical Center), Harris G. Yfantis(University of Maryland, Baltimore), Tim Hon Man Chan(Sun Yat-sen University), Aaron J. Schetter(AstraZeneca (Singapore)), Geng Zhang(Hebei Medical University), Peijun He(University of Maryland, Baltimore), Curtis Lacy(National Institutes of Health), H. Richard Alexander(Umeå University), Jonathan M. Weiss(Max Planck Institute for Metabolism Research), Dong Hoon Lee(Korea University), Michael Ghadimi(Universitätsmedizin Göttingen)
Cited by 141
Related Papers
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine
|Science|2017|1.8k
<i>DAXX</i> / <i>ATRX</i> , <i>MEN1</i> , and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors
|Science|2011|1.7k
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k